Glossary

    Section 503B Outsourcing Facility

    FDA-registered facilities that compound medications in larger quantities without individual prescriptions.

    Definition

    Section 503B outsourcing facilities are referenced in the regulatory status details tracked for peptides on TruthTides. Unlike 503A pharmacies, 503B facilities are registered with the FDA and can produce compounded medications in larger quantities without individual patient prescriptions. They are subject to FDA inspection and must comply with current good manufacturing practice (cGMP) requirements.

    Source: Regulatory status details database